General Information
Version
0.0
Revision date
2023-10-21
Product name
Medroxyprogesterone Acetate Injectable Suspension USP 150mg_mL 1mL
1.2.1 Relevant identified uses
Industrial/Professional use spec Industrial
Emergency telephone
34 987 878 000
Icons in SDS
Company Information
company name
FARMALAN
e-mail address of the competent person responsible for the Safety Data Sheet
jairo.pelaez@chemogroup.net
Section 2
SECTION 2: Hazards identification
1272/2008 Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice
Other hazards which do not result in classification
According to Article 1, item 5 (a) of CLP Regulation (EC) 1272/2008, medicinal products in the finished state for human use, as defined in 2001/83/EC, are excepted from classification and
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Not classified Adverse physicochemical, human health and environmental effects To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice.
